Research & Development



  “廷尉,衛尉,中尉的職責你真的弄清楚了?” 2014注册送彩票体验金   一個黑陶紅紋的酒壇子被紅袖泡在一個裝滿開水的木盆里,然後就有兩個健壯的僕婦抬著木盆,安放在東方朔身邊,酒壇子雖然沒有開,僅僅從價值不菲的酒壇子上,東方朔,就知道這一壇子酒應該不是他平日里喝的粗酒。252期3d福利彩票开奖   看著殺豬匠一般的醫生,伸著一雙黑不拉嘰的手就開始為軍卒處理傷患,雲瑯實在是看不下去了,他決定還是自己動手的好。   大長秋冷哼道︰“你自己行為不檢,還埋怨別人都知道?要想人不知除非己莫為!最看不起你們這種浮華浪子,仗著腰間有一個子孫根就肆意胡為,卻不知道那也是惹禍的根苗。你看著吧,以後有你煩惱的地方呢。”2014足球世界杯彩票   他覺得老虎鋒利的牙齒會在某一個瞬間, 嚓一下咬斷小蟲細細的手腕。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo